CorneaGen

CorneaGen is a commercial-stage company and a world-leading eye bank specializing in corneal transplant tissue and regenerative medicine. Its core offering is CTAK, a gamma-irradiated, sterile, and customized corneal tissue inlay, alongside a portfolio of surgical products like the EndoSerter and VisionGraft. The company leverages its extensive tissue processing capabilities, surgeon education programs, and strategic partnerships to address corneal blindness, positioning itself as an integrated provider in the ophthalmic surgery ecosystem.

Advanced tissue processing platform utilizing laser-cutting and gamma irradiation to create sterile, non-immunogenic, and customizable corneal tissue inlays (CTAK), supported by a suite of specialized surgical instruments for corneal transplantation.

CorneaGen competes with other large non-profit eye banks (e.g., Eversight, Lions Eye Institute) for tissue procurement and distribution. In the surgical product space, it faces competition from established ophthalmic device companies (e.g., Alcon, Bausch + Lomb) and specialized tool manufacturers. Its integrated model of tissue supply plus proprietary products is a key differentiator.